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The rates of accumulation, influx and eftlux of vincristine have been examined in a series of multidrug-resistant Chinese hamster ovary cell lines 
which show exceptionally high levels of hypersensitivity (collateral sensitivity) to several resistance modifiers. The more highly resistant members 
of the series show significantly reduced levels of vincristine influx compared to the control cell line from which they were derived. It is possible 
that resistance modifier hypersensitivity and reduced vincristine influx may be due to a common change in membrane composition which has arisen 
during prolonged selection for vincristine resistance in these cell lines. 
Multidrug resistance (CHO cells); Vincristine; Drug influx 
1. INTRODUCTION 
Multidrug resistance involves the simultaneous devel- 
opment of resistance to a wide range of structurally and 
functionally unrelated cytotoxic drugs to which cells 
have not previously been exposed [1,2]. Multidrug re- 
sistant cells characteristically overexpress a group of 
plasma membrane glycoproteins with an M, of 170,OOCL 
180,000, termed P-glycoproteins [3,4] encoded by a fam- 
ily of three closely related genes in rodents and two 
genes in humans. Multidrug resistance can usually be 
reversed by a range of compounds which are known 
collectively as resistance modifiers, the most extensively 
studied of which is verapamil [5]. P-glycoproteins are 
thought to act as energy-dependent efflux pumps and 
the reduced drug accumulation which is commonly ob- 
served in multidrug resistant cell is normally attributed 
primarily to increased drug efflux consequent upon the 
elevated levels of P-glycoprotein in the cell membranes 
of these cells. However, some studies have indicated 
that the mechanism of reduced accumulation may be 
more complex in some cases, possibly involving reduced 
influx or redistribution of drugs within the cell. For 
example, Sirotonak et al. [6] observed a 24-fold decrease 
in influx of vincristine but only a 2-fold increase in 
vincristine eftlux in highly vincristine resistant (2,750- 
fold) Chinese hamster lung cells. Trans-inhibition stud- 
ies showed that efflux of preloaded, unlabelled drug 
inhibited the influx of labelled drug, suggesting that 
influx and eftlux pathways interact and are not com- 
pletely independent. Bradley et al. [I], in reviewing the 
mechanisms underlying multidrug resistance, con- 
cluded that the available experimental data on drug 
transport suggested that the two proposed mechanisms 
of drug efflux and drug influx permeability barrier are 
not mutually exclusive, but may represent different as- 
pects of a pleiotropic alteration in membrane function 
that results in reduced drug accumulation. Jardillier et 
al. [7] have recently reported a reduction in vinblastine 
influx in vinblastine resistant human leukaemic lym- 
phoblast CEM cells. 
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In the present study, we have analysed the rates of 
vincristine influx and efflux in multidrug resistant Chi- 
nese hamster ovary cell lines which show much lower 
levels of vincristine resistance than those studied by 
Sirotonak et al. [6]. These cell lines comprise the VRT 
series, VRTS, VRTl5, and VRT25, which were selected 
by 5, 15 and 25 sequential exposures to increasing con- 
centrations of vincristine respectively, and the VRA se- 
ries, VRA5 and VRA 15, which were independently se- 
lected by 5 and 15 rounds of vincristine selection, re- 
spectively. We have previously shown that the cell lines 
obtained after 15 and 25 rounds of selection exhibit an 
unusually high degree of hypersensitivity (collateral sen- 
sitivity) to verapamil and to other resistance modifiers 
such as nicardipine, diltiazem and quinidine sulphate 
[8,9]. The cell lines VRA15 and VRTl5 have been 
shown to have reduced verapamil accumulation [lo]. 
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They are cross-resistant to cyclosporin A, which can act 
as a multidrug resistance modifier [l 11. 
In the present work, measurement has been made of 
the vincristine accumulation, influx and efflux on these 
cell lines in order to broaden our understanding of the 
membrane physiology of these multidrug resistant cell 
lines which show an exceptional level of hypersensitivity 
to resistance modifiers, and also to complement Si- 
rotnak’s studies [6] on very much more highly vin- 
cristine resistant hamster cell lines. 
2. EXPERIMENTAL 
The origin of the cell lines VRAS, VRAl5, VRTS, VRTl5 and 
VRT25 has been described previously [8,9]. VRA15 and VRTl5 were 
referred to as VCR/A and VCR/T respectively in [8]. Cell lines were 
cultured in Glasgow MEM with 10% foetal calf serum in a 5% CO2 
humidified incubator. 
For accumulation, influx and eftlux measurements, cells were 
grown in monolayer culture and harvested by 5 min exposure to 0.25% 
trypsin. After addition of an equal volume of medium, the cell suspen- 
sion was pelleted by centrifugation, washed in 2 ml medium containing 
20 mM HEPES (pH 7.2) and resuspended in 3 ml of medium contain- 
ing HEPES. 
For accumulation and influx measurements, the cells were incu- 
bated with shaking for 1 h to recover from the trypsin treatment. To 
commence the experiment, cold and [‘Hlvincristine (Amersham) were 
added to a total concentration of 10 PM and 0.025-0.04 MBq/ml. 
Duplicate samples were removed at time intervals and rapidly added 
to lo-fold volume of ice-cold 0.14 M NaCl, 0.01 M KPO, pH 7.2 
buffered isotonic saline. The cells were washed twice by centrifugation 
and resuspension i  ice-cold buffered saline. Finally the cell pellet was 
resuspended in 1% (w/v) SDS to lyse the cells before scintillation 
counting. For accumulation measurements, the initial drug bound to 
the cells during the first 15 s of the experiments was excluded from the 
calculation. For comparisons of intracellular drug concentrations, 
drug accumulation per cell was converted to drug concentrations for 
each cell line using cell volume measurements made with a Coulter ZM 
counter. 
For efflux experiments, cells prepared as above were preloaded by 
incubation with gentle shaking for 1 h with 10,~M vincristine, contain- 
ing between 0.0254.06 Mq/ml [‘Hlvincristine. After this period, cells 
were pelleted and washed briefly in ice-cold PBS solution. Finally, the 
pellet was resuspended in 2.5 ml of prewarmed (37°C) medium con- 
taining HEPES and transferred to a 37°C shaking waterbath. At 
various time intervals, duplicate aliquots were removed and spun in 
a microcentrifuge for 30 s and the pellets washed briefly before being 
resuspended in 1% (w/v) SDS prior to scintillation counting. Signifi- 
cance testing of differences between influx or efflux rates of different 
cell lines was performed by covariance analysis using a program writ- 
ten by Dr. J.G. Hastewell. 
3. RESULTS 
3.1. Vincristine accumulation 
The time course of vincristine accumulation by the 
sensitive cell line E29 and the VRT series of multidrug- 
resistant cell lines is shown in Fig. 1. It can be seen that 
that accumulation is rapid for the first 10 min, after 
which time the rate of accumulation is considerably 
reduced. The independently selected cell lines, VRAS 
and VRAl.5 showed very closely similar time course for 
vincristine accumulation as VRTS and VRTlS respec- 
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Fig. 1. Time course of vincristine accumulation by the sensitive cell 
line, E29 and by the multidrug-resistant cell lines, VRT5, VRTl5 and 
VRT25, incubated in 10pM vincristine at 37°C. Each point represents 
the mean of 6 measurements. Vertical lines represent he S.E.M. 
tively. It has been shown previously by HPLC analysis 
that [3H]vincristine isnot metabolised in CHO cells [12], 
so the accumulated material is assumed to be in the 
form of the original drug. Values for total drug accumu- 
lation for all cell lines after 30 min, expressed as a ratio 
of intracellular to extracellular drug concentrations, are 
presented in Table I. It can be seen from Fig. 1 and 
Table I that there is an inverse correlation between drug 
accumulation and vincristine resistance levels. The least 
resistant members, VRAS and VRTS, show only slight 
reduction in drug accumulation. The moderately re- 
sistant cell lines VRAl5, VRT15 and VRT25 do have 
a highly significant reduction in accumulation, as would 
be expected. However, although VRT25 is a more 
highly resistant derivative of VRT15, we were not able 
Table I 
Vincristine accumulation, eflhrx and influx of the VRA and VRT 
series of multidrug resistant CHO cells 
Cell line Vincristine Vincristine Vincristine Vincristine 
resistance accumulation eMlux influx 
E29 (1) (1) (1) (1) 
VRA5 3.2 0.88 1.10 1.15 
VRAl5 61 0.13*** 0.89 0.21** 
VRT5 9.7 0.57** 0.81 0.81” 
VRT15 58 0.07*** 0.63 0.21*** 
VRT25 87 0.08*** 0.86 0.14*** 
All values are expressed relative to the sensitive cell line, E29. Signif- 
icance levels are given for each value relative to the corresponding 
value for E29, with * for 58, ** for 1% and *** for 0.1% significance 
levels, respectively. Tests of significance are by Student’s r-test for 
accumulation and by covariance analysis for efllux and for influx. 
Values for relative vincristine resistance levels have been published 
previously [9], and are given for comparison with the accumulation, 
efflux and influx data. 
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Fig. 2. Loss of vincristine from sensitive cells, E29, and multidrug- 
resistant cells, VRT15, following 30 min preloading with 10 PM vin- 
cristine. Each point is the mean of 6 measurements. 
to detect a significant difference in the levels of vin- 
cristine accumulation between these two cell lines. 
3.2. Vincristine ef$ux 
Preliminary experiments howed that there was no 
detectable drug efflux from sensitive or resistant cell 
lines at 0°C (data not shown), although very rapid ef- 
flux occurred at 37°C from both sensitive and resistant 
cell lines. This preliminary experiment established that 
efflux did not continue during the washing on stop 
buffer, and was necessary before performing experi- 
ments to determine the contribution of increased efhux 
to the reduced accumulation of vincristine at 37°C. Ef- 
flux rates at 37°C were shown to be biphasic in sensitive 
and resistant cells (Fig. 2). This phenomenon has been 
reported previously by Sirotonak et al. [6] and it is 
thought that the initial rapid component of 10-15 min 
represents efflux of exchangeable, unbound drug, 
whereas the subsequent second, slower component rep- 
resents the rate of dissociation (off rate) of intracellu- 
larly bound drug. The rates of eftlux of free drug from 
the cell lines were therefore measured uring the first 10 
min of efflux and are given in Table I. Slight differences 
in efflux rates exist in the resistant cell lines in compar- 
ison with the sensitive cell line E29, but none of the 
differences were found to be significant at the 5% prob- 
ability level by covariance analysis. 
3.3. Vincristine injlux 
Influx measurements were performed in order to as- 
sess the role of changes in influx on the decreased accu- 
mulation observed in these multidrug resistant cell lines. 
During the period of 5 min in which the measurements 
were made, entry of the drug was linear with time at a 
concentration of 10 PM vincristine in parental and drug 
resistant cell lines (Fig. 3). There was a linear relation- 
ship between the external concentration of vincristine 
and the rate of vincristine influx over a wide range of 
concentrations (Fig. 4). 
Rates of vincristine influx of the sensitive cell line, 
E29 and the resistant cell lines of the VRA and VRT 
series are shown in Table I. The low level resistant cell 
lines VRA5 and VRT5 have similar rates of influx to 
those of E29 cells. However, the rate of influx is reduced 
fivefold in VRA15 and in VRT15 and sevenfold in 
VRT25. Overall, there is a very strong negative correla- 
tion (correlation coefficient, -0.95) between increased 
levels of resistance and influx rates. 
4. DISCUSSION 
The multidrug resistant CHO cell lines studied here 
show a reduction in vincristine accumulation which is 
approximately proportional to resistance levels, as has 
been widely observed for many multidrug resistant cell 
lines [l]. There is not a simple linear relationship be- 
tween the two, however, because we did not detect a 
difference in the levels of vincristine accumulation be- 
tween VRT15 and VRT25, although they have a signif- 
icantly different level of resistance. 
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Fig. 3. Time course for the influx of vincristine at 37°C in the sensitive 
cell line, E29, and the multidrug-resistant cell line, VRAlS, during 
incubation in 10 PM vincristine. Each point represents the mean of 6 
measurements. Vertical lines represent he S.E.M. 
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Fig. 4. Concentration dependence of vincristine influx in the sensitive 
cell line, E29, and the multidrug-resistant cell line, VRAlS at 37°C. 
Each point represents the mean of 6 measurements. Vertical lines 
represent he S.E.M. 
The unusual feature of the reduction in drug accumu- 
lation observed in these cells is that it does not appear 
to be simply attributable to increased drug efflux and 
there is an appreciable reduction in influx in all except 
the least resistant cell lines. These results complement 
earlier observations by Sirotnak et al. [6] who were 
working with very much more highly vincristine re- 
sistant cells. These authors observed that in Chinese 
hamster lung cells, which were approximately thirty 
fold more resistant than the most highly resistant cell 
lines studied here (2,750-fold compared with 87-fold), 
decreased vincristine accumulation involved a 24-fold 
reduction in influx, and only a twofold increase in vin- 
cristine efflux. Our results suggest hat this general con- 
clusion also holds for some hamster cell lines with a very 
much lower level of vincristine resistance. 
It is of interest hat the multidrug resistant cells stud- 
ied by Sirotnak were selected on the basis of vincristine 
resistance, as in the case of the cells studied in this work, 
and also that the daunomycin cross-resistance of the 
cells studied by Sirotnak did not involve any change in 
daunomycin influx. It may therefore be possible that the 
involvement of reduced drug influx is a feature of vin- 
cristine resistance in a subset of multidrug resistant cells 
which have been selected for resistance by prolonged 
culture in vincristine, not occurring in multidrug re- 
sistance to other drugs or selected by exposure to other 
drugs. It is possible to speculate on how this may arise. 
Vinca alkaloids are known to interact directly with 
membranes to induce changes in phospholipid composi- 
tion [ 131 and in physical properties [ 14,151. These drug 
induced changes are likely to have detrimental effects on 
the normal functioning of the cell membranes and hence 
on cell growth and survival. During prolonged exposure 
to high vincristine concentrations, selection pressure 
will be exerted in favour of those variants which have 
compensatory changes in membrane composition and 
structure which go some way to reverse the drug in- 
duced membrane abnormalities. Thus, multidrug re- 
sistant cells selected by prolonged exposure to vin- 
cristine may have characteristic membrane changes 
which in turn may influence some aspects of membrane 
functioning, possibly including those involved in vin- 
cristine influx. Sirotnak et al. [6] have presented evi- 
dence suggesting that a carrier is involved in influx of 
vincristine. The speculated membrane changes outlined 
above may have led to reduced accessibility of such a 
carrier and hence reduced influx of vincristine. 
Although there have been several reports of mul- 
tidrug resistant cell lines showing hypersensitivity (col- 
lateral sensitivity) to resistance modifiers [l&18], cell 
lines of this series have higher levels than is generally 
observed in other multidrug resistant cell lines. Hy- 
persensitivity arises in these cells to a wide range of 
modifiers, which include the calcium channel blockers 
verapamil, diltiazem and nicardipine and the membrane 
active agent, quinidine sulphate. It has been proposed 
that this hypersensitivity arises in cells of this series due 
to the presence of abnormal composition and structure 
of membranes which render them unusually sensitive to 
membrane destabilising effects of resistance modifiers 
[8-IO]. Such membrane abnormalities may be the same, 
or share some common features with, those membrane 
abnormalities which are proposed here to contribute to 
reduced vincristine influx. In order to explore this possi- 
bility further, it would be of interest o examine whether 
the highly vincristine resistant cell lines with reduced 
influx studied by Sirotnak [6] exhibit hypersensitivity to 
resistance modifiers. 
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